Cancer research has significantly advanced in understanding prevention and epidemiology, offering hope for reducing its global burden. Prevention focuses on mitigating risk factors like tobacco use, poor diet, and sedentary lifestyles. Public health initiatives, including vaccinations for HPV and hepatitis B, have proven effective in lowering incidences of cervical and liver cancers.
Epidemiology provides valuable insights by studying cancer patterns, causes, and distribution. It helps identify high-risk populations and environmental triggers, paving the way for targeted interventions. Advances in genetic profiling further enable the early detection of hereditary cancers. Combining these strategies enhances cancer prevention, fostering healthier communities and improving global health outcomes.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China